ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
ton9031
|
12K |
3.8M |
1 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
12K
|
3.8M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
ton9031
|
12K |
3.8M |
0 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
12K
|
3.8M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
ton9031
|
12K |
3.8M |
1 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
12K
|
3.8M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
ton9031
|
943 |
415K |
6 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
943
|
415K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
ton9031
|
274 |
111K |
3 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
274
|
111K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change of Director's Interest Notice - Silviu Itescu
|
|
ton9031
|
185 |
50K |
2 |
23/12/23 |
23/12/23 |
ASX - By Stock
|
185
|
50K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ton9031
|
18K |
7.1M |
3 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
18K
|
7.1M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ton9031
|
18K |
7.1M |
4 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
18K
|
7.1M
|
4
|
|
Charts
|
SMN |
Re:
SMN - Chart
|
|
ton9031
|
3.4K |
1.4M |
6 |
07/09/23 |
07/09/23 |
Charts
|
3.4K
|
1.4M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Insider bullish on MSB prior fda approval
|
|
ton9031
|
164 |
59K |
1 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
164
|
59K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
ton9031
|
6.0K |
3.0M |
14 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
6.0K
|
3.0M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
ton9031
|
6.0K |
3.0M |
1 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
6.0K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
ton9031
|
6.0K |
3.0M |
2 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
6.0K
|
3.0M
|
2
|
|
ASX - By Stock
|
SMN |
Re:
Show me a sign
|
|
ton9031
|
58 |
20K |
0 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
58
|
20K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
ton9031
|
4.7K |
1.1M |
1 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
4.7K
|
1.1M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
ton9031
|
4.7K |
1.1M |
5 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
4.7K
|
1.1M
|
5
|
|
ASX - By Stock
|
SMN |
Re:
SMN , Heinrich Loechteken
|
|
ton9031
|
301 |
74K |
2 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
301
|
74K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
50 cents
|
|
ton9031
|
101 |
28K |
2 |
04/06/22 |
04/06/22 |
ASX - By Stock
|
101
|
28K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
50 cents
|
|
ton9031
|
101 |
28K |
2 |
04/06/22 |
04/06/22 |
ASX - By Stock
|
101
|
28K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB $1 Party
|
|
ton9031
|
1.1K |
363K |
3 |
23/04/22 |
23/04/22 |
ASX - By Stock
|
1.1K
|
363K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
ton9031
|
1.5K |
516K |
10 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
1.5K
|
516K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
MSB $1 Party
|
|
ton9031
|
1.1K |
363K |
2 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
1.1K
|
363K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
ton9031
|
880 |
220K |
4 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
880
|
220K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
ton9031
|
880 |
220K |
4 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
880
|
220K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C Quarterly Activity Report
|
|
ton9031
|
173 |
48K |
4 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
173
|
48K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: CHF Late Breaker Presentation at American Heart Association
|
|
ton9031
|
350 |
128K |
5 |
09/10/21 |
09/10/21 |
ASX - By Stock
|
350
|
128K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Rem-L needed Yesterday
|
|
ton9031
|
9 |
1.9K |
2 |
25/09/21 |
25/09/21 |
ASX - By Stock
|
9
|
1.9K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Rem-L needed Yesterday
|
|
ton9031
|
9 |
1.9K |
1 |
25/09/21 |
25/09/21 |
ASX - By Stock
|
9
|
1.9K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Rem-L needed Yesterday
|
|
ton9031
|
9 |
1.9K |
1 |
25/09/21 |
25/09/21 |
ASX - By Stock
|
9
|
1.9K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Rem-L needed Yesterday
|
|
ton9031
|
9 |
1.9K |
3 |
25/09/21 |
25/09/21 |
ASX - By Stock
|
9
|
1.9K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
ton9031
|
10K |
3.1M |
9 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
10K
|
3.1M
|
9
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
ton9031
|
10K |
3.1M |
2 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
10K
|
3.1M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
ton9031
|
10K |
3.1M |
1 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
10K
|
3.1M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
ton9031
|
10K |
3.1M |
0 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
10K
|
3.1M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
ton9031
|
10K |
3.1M |
0 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
10K
|
3.1M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
ton9031
|
10K |
3.1M |
6 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
10K
|
3.1M
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
ton9031
|
10K |
3.1M |
23 |
17/09/21 |
17/09/21 |
ASX - By Stock
|
10K
|
3.1M
|
23
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
ton9031
|
10K |
3.1M |
3 |
30/08/21 |
30/08/21 |
ASX - By Stock
|
10K
|
3.1M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
ton9031
|
4.7K |
1.1M |
0 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
4.7K
|
1.1M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB website indicates Novartis agreement as conditions met.
|
|
ton9031
|
158 |
47K |
7 |
22/08/21 |
22/08/21 |
ASX - By Stock
|
158
|
47K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB website indicates Novartis agreement as conditions met.
|
|
ton9031
|
158 |
47K |
5 |
22/08/21 |
22/08/21 |
ASX - By Stock
|
158
|
47K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ton9031
|
18K |
7.1M |
2 |
22/08/21 |
22/08/21 |
ASX - By Stock
|
18K
|
7.1M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Trading Halt on Announcement
|
|
ton9031
|
20 |
6.6K |
7 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
20
|
6.6K
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
ton9031
|
10K |
3.1M |
6 |
05/08/21 |
05/08/21 |
ASX - By Stock
|
10K
|
3.1M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Moderated
|
|
ton9031
|
1.5K |
511K |
6 |
03/08/21 |
03/08/21 |
ASX - By Stock
|
1.5K
|
511K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C Quarterly Activity Report
|
|
ton9031
|
281 |
79K |
3 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
281
|
79K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
ton9031
|
10K |
3.1M |
2 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
10K
|
3.1M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
ton9031
|
18K |
7.1M |
3 |
13/07/21 |
13/07/21 |
ASX - By Stock
|
18K
|
7.1M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast readies $100m private placement
|
|
ton9031
|
396 |
119K |
2 |
28/02/21 |
28/02/21 |
ASX - By Stock
|
396
|
119K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast readies $100m private placement
|
|
ton9031
|
396 |
119K |
1 |
28/02/21 |
28/02/21 |
ASX - By Stock
|
396
|
119K
|
1
|
|